Author Archives: "Elizabeth Porco"

Elizabeth Porco

Scientists Develop System for Early Diagnosis of Parkinson’s, MS, and Alzheimer’s
Virtual reality diagnosis using a new mathematical model linked to balance can detect first signs of these disorders, it is [...]
Tysabri May be More Effective than Gilenya at Reducing Disease Activity in MS Patients
An indirect comparison of results from randomized clinical trials in relapsing-remitting multiple sclerosis (RRMS) patients suggests [...]
Lifelong Exercise Doesn’t Lower the Risk of MS, Large Study in Women Reports
In a large prospective study with validated measures of physical activity, researchers found no evidence that exercise reduced a woman’s [...]
Satisfaction with MS Therapy Influenced by Doctor-Patient Communication, Study Finds
A study published in the BMC Neurology journal emphasized that clear and regular communication between physicians and patients with [...]
MS More Frequent Among Females Exposed to High Levels of Copper, Study Shows
Exposure to heavy metals and being female are associated with a higher incidence of multiple sclerosis (MS), according to a study conducted [...]
How Tecfidera Works to Reduce MS Relapses Discovered, May Lead to Better Treatments
How the multiple sclerosis (MS) therapy Tecfidera (dimethyl fumarate) works on a molecular level has finally been uncovered, using a new [...]
Protein Biomarker Identified for MS May Predict Disease Severity, Treatment Response
A newly discovered potential biomarker of multiple sclerosis (MS) may help to distinguish between people who will go on to have less severe [...]
Experimental Drug May Prevent Development of Multiple Sclerosis in Mice
The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to [...]
8 less common symptoms of multiple sclerosis
Multiple sclerosis (MS) results when the body’s immune system starts to attack and destroy myelin, the protecting coating on nerve fibers [...]
Can multiple sclerosis be detected by biomarkers in the blood? yes, study says
MicroRNAs present in the blood show promise as potential biomarkers of multiple sclerosis (MS), a new study suggests. The study, titled [...]
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

Upcoming Testing Periods

WINTER 2024 TESTING PERIOD

Application Deadline: December 6th, 2023

First Day of Testing: Saturday, January 6th, 2024

Last Day of Testing: Saturday, January 20th, 2024

SUMMER 2024 TESTING PERIOD

Application Deadline: May 1st, 2024

First Day of Testing: Saturday, June 1st, 2024

Last Day of Testing: Saturday, June 15th, 2024

Resources

Visit PTC to download a PDF version of the Handbook. Candidates can also apply online.

For more information:

Professional Testing Corporation http://www.ptcny.com/

  • 212-356-0660
  • 1350 Broadway, 17th Floor, New York, NY 10018

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM